Heart with fenestrations symbolizing hidden complexities.

Unmasking Hidden Heart Defects: Why a Second Look Can Save Lives

"A case study highlights the importance of thorough cardiac imaging in diagnosing fenestrated atrial septal defects, preventing complications from incomplete closure."


Atrial septal defects (ASDs), or holes in the heart's wall between the two upper chambers, can range in complexity. While some are straightforward to diagnose and treat, others, particularly fenestrated ASDs—those with multiple small openings—present a significant challenge. Often missed during initial assessments, these defects can lead to incomplete closure and persistent symptoms if not properly identified.

A recent case involving a 22-year-old woman underscores the importance of thorough investigation and advanced imaging techniques in diagnosing and managing complex ASDs. Her journey from initial diagnosis to successful surgical correction sheds light on the potential pitfalls of relying on limited diagnostic information.

Initially diagnosed with a simple ASD, she experienced ongoing chest pain and shortness of breath despite a percutaneous closure attempt. This article will explore how advanced imaging revealed the presence of multiple fenestrations, ultimately leading to the patient's successful surgical outcome and highlighting crucial lessons for clinicians.

AI Search Multiple angles on this topic

ASD Prevalence and Adult Presentation

Atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the septum dividing the upper chambers of the heart, with a birth prevalence of approximately 2.5 per 1,000 live births. Notably, 25% to 30% of ASD cases present in adulthood rather than being detected in childhood, meaning many patients carry an undiagnosed shunt for years. ASD allows left-to-right shunting at the atrial level, promoting right-sided cardiac overload and dysfunction, and serves as a conduit between systemic and pulmonary circulation. Because many cases are diagnosed later in adulthood, understanding their demographic characteristics and clinical features is essential for optimizing long-term outcomes.

Current Treatment Paradigms

The current standard approach to ASD management centers on closure of the defect, either through minimally invasive transcatheter device delivery or surgical repair. Transcatheter closure has become an accepted and widely adopted alternative to open-heart surgery, offering patients a less invasive option with generally favorable recovery profiles. However, the effectiveness of these methods depends on defect anatomy and patient-specific factors, and not every case is straightforward. Patients with complex anatomy or borderline physiology may face limitations with standard closure techniques, and some require more individualized treatment strategies.

Evolution of ASD Treatment

The understanding and treatment of atrial septal defects have evolved considerably over the past several decades. Early detection relied heavily on clinical examination and basic imaging, with many cases going undiagnosed until adulthood. Over time, advances in cardiac catheterization and echocardiography transformed the diagnostic landscape, enabling earlier identification of defects. Surgical closure was historically the primary treatment, but the development of transcatheter techniques marked a significant milestone, expanding options for patients who might otherwise require open-heart surgery.

The Case of the Missed Fenestrations: A Diagnostic Puzzle

Heart with fenestrations symbolizing hidden complexities.

The patient, already diagnosed with ASD, presented with worsening chest pain and dyspnea. An initial transthoracic echocardiogram indicated a dilated right ventricle and a right-to-left shunt, leading to a planned percutaneous closure with an Amplatzer device. However, a post-procedure echocardiogram revealed multiple additional defects and residual flow across the interatrial septum.

This unexpected finding prompted the removal of the closure device and a referral for surgical intervention. To better characterize the defect, a phase-contrast magnetic resonance imaging (MRI) was performed, revealing a large ASD with multiple small fenestrations along the inferior aspect.

  • Initial Presentation: Symptoms of chest pain and dyspnea despite prior ASD diagnosis.
  • Initial Echocardiogram: Showed right ventricle dilation and right-to-left shunt.
  • Failed Percutaneous Closure: Post-procedure imaging revealed multiple residual defects.
  • MRI Findings: Confirmed a large ASD with multiple fenestrations.
AI Search Multiple angles on this topic

Novel Techniques for Complex ASD Closure

Recent research has focused on addressing the challenges posed by complex, multifenestrated atrial septal defects that resist standard single-device closure. A July 2026 study described the use of transcatheter electrosurgical septal tendon transection, a technique designed to consolidate a fenestrated ASD into a single defect suitable for single-device closure. In clinical practice, a 55-year-old male with complex multifenestrated ASD was successfully treated using transcatheter repair, though such cases highlight that multi-fenestrated defects pose unique challenges. Extensive review literature also emphasizes ASD's link with pulmonary arterial hypertension (PAH), noting that significant knowledge gaps and clinical uncertainties remain regarding this association.

Limitations and Ongoing Challenges

Despite the growing success of transcatheter ASD closure, significant challenges persist, particularly for patients with complex defect anatomies. The presence of multiple defects or interatrial aneurysm with fenestrations remains a potential limitation for any device closure approach, and these cases are associated with a higher incidence of complications. Not every defect is amenable to percutaneous repair, and patient selection remains a critical factor in treatment success. The field continues to grapple with identifying the optimal approach for borderline cases where standard protocols may not apply.

Device Closure vs. Surgical Repair

Transcatheter closure has become the first-line treatment for most secundum ASDs, with its first attempt dating back to 1976 by Mills and King. A systematic review comparing percutaneous device closure with minimally invasive cardiac surgery (MICS) found that MICS is also safe and effective, with comparable mortality and morbidity and superior cosmetic results compared to conventional median sternotomy. While device closure remains the preferred approach for simple defects, multiple defects and interatrial aneurysm with fenestrations are still associated with a higher incidence of complications and represent potential limitations for device-based repair. The choice between approaches ultimately depends on defect complexity, patient anatomy, and the available device options.

Surgical intervention confirmed the presence of multiple fenestrations, which were surgically removed, and the resulting defect was closed using bovine pericardium. Post-surgery, the patient reported improvement in her dyspnea, although chest pain persisted, indicating the complex nature of managing such conditions.

The Importance of Comprehensive Cardiac Imaging

This case underscores the critical importance of comprehensive cardiac imaging in diagnosing complex ASDs, particularly fenestrated defects. While 2-dimensional echocardiography is a valuable tool, it has limitations in detecting multiple fenestrations due to its single-plane imaging.

AI Search Multiple angles on this topic

Expert Guidance on Treatment Strategy

Recent expert commentary emphasizes that transcatheter ASD closure demonstrates high success rates, with balloon- and guidewire-assisted implantations showing favorable outcomes. Smaller device-to-balloon sizing differences have been identified as predictors of clinical failure, highlighting the importance of precise sizing during device selection. For patients with borderline or high-risk profiles, fenestrated or staged closure strategies may be considered as viable alternatives to complete one-stage closure. In patients who also present with atrial arrhythmias, ASD closure should be integrated into a broader management plan that includes rhythm control and stroke prevention strategies.

Emerging Directions in ASD Management

The field of ASD management continues to evolve, with emerging techniques and device innovations expanding treatment possibilities for patients with previously challenging defect anatomies. As transcatheter methods become more sophisticated, the range of defects amenable to catheter-based repair is expected to broaden further. Ongoing research into the relationship between ASD and pulmonary arterial hypertension may also reshape treatment guidelines and patient selection criteria. The trajectory suggests that personalized, anatomy-driven treatment approaches will become increasingly central to ASD care.

The Diagnostic Blind Spot

A significant systemic challenge in ASD detection is what has been described as a bidirectional cardiopulmonary diagnostic blind spot. Dyspnea in adults with secundum ASD is often attributed primarily to shunt physiology, while coexisting airway disease may remain unrecognized. Conversely, clinically significant ASD may be overlooked in patients presenting with predominant respiratory symptoms, leading clinicians to focus on pulmonary rather than cardiac causes. This diagnostic overlap between cardiac and respiratory presentations represents a broader challenge that can delay timely identification and treatment of ASD in affected adults.

Real-World Cases and Personalized Solutions

Real-world case reports illustrate both the severity of missed ASDs and the ingenuity of modern treatment solutions. A large secundum ASD measuring 48 by 54 mm with a predominantly left-to-right shunt was identified in one patient through transesophageal echocardiography. Transcatheter closure of secundum ASDs measuring less than 38 mm is the preferred treatment when margins are adequate, but for larger defects, custom solutions have been developed, including a fenestrated 48 mm septal occluder successfully used to treat an elderly hypertensive male. In cases of coexisting left ventricular dysfunction or valvular disease, where standard closure carries a risk of pulmonary congestion, implantation of a fenestrated device serves as an important therapeutic option.

The American Society of Echocardiography recommends 3-dimensional transesophageal echocardiography for all adult patients being evaluated for percutaneous transcatheter closure or surgical therapy. This technique provides an en face view of the ASD, improving the detection of additional fenestrations.

In conclusion, this case serves as a reminder that a thorough diagnostic approach, incorporating advanced imaging modalities, is essential for accurate diagnosis and effective management of complex congenital heart defects. This leads to better patient outcomes and reduces the need for repeat interventions.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1161/circimaging.118.007192, Alternate LINK

Title: Case Of Delayed Diagnosis Of Fenestrated Atrial Septal Defect

Subject: Cardiology and Cardiovascular Medicine

Journal: Circulation: Cardiovascular Imaging

Publisher: Ovid Technologies (Wolters Kluwer Health)

Authors: Todd Looney, Gregory R. Czaja, Michael Casey Flanagan, Junewai L. Reoma, Edward Hulten

Published: 2018-10-01

Everything You Need To Know

1

What exactly is a fenestrated Atrial Septal Defect, and why is it harder to diagnose?

A fenestrated Atrial Septal Defect refers to an Atrial Septal Defect that has multiple small openings instead of just one. These multiple openings can make them more difficult to detect and completely close during initial treatments, potentially leading to persistent symptoms and the need for further intervention.

2

Why can't a standard Echocardiogram always detect a fenestrated Atrial Septal Defect?

While an initial Transthoracic Echocardiogram is useful, it may not always be sufficient for detecting fenestrated Atrial Septal Defects. Due to the limitations of single-plane imaging, multiple small fenestrations can be missed. Advanced imaging techniques like phase-contrast Magnetic Resonance Imaging are often necessary to fully characterize the defect and ensure accurate diagnosis.

3

In the described case, how did doctors discover the initial Atrial Septal Defect closure was incomplete?

In the described case, the patient initially underwent a percutaneous closure using an Amplatzer device after an initial Echocardiogram suggested a simple Atrial Septal Defect. However, post-procedure imaging revealed multiple additional defects, indicating the presence of a fenestrated Atrial Septal Defect that was not initially detected. This led to the removal of the device and a referral for surgical intervention.

4

What happens if a fenestrated Atrial Septal Defect isn't correctly identified and fully treated?

If a fenestrated Atrial Septal Defect is not properly identified and treated, it can lead to incomplete closure of the defect. This can result in persistent symptoms like chest pain and dyspnea (shortness of breath), as well as potential complications related to blood flow abnormalities. In such cases, further interventions, such as surgical repair, may be necessary to fully correct the defect.

5

What was the outcome for the patient after surgical correction of the fenestrated Atrial Septal Defect, and were all symptoms resolved?

After the surgical removal of fenestrations and closure of the Atrial Septal Defect using bovine pericardium, the patient reported an improvement in dyspnea. However, chest pain persisted, highlighting the complex nature of managing such conditions. This suggests that while the structural defect was corrected, other factors might be contributing to the ongoing chest pain, requiring further evaluation and management.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.